Connect Biopharma

Connect Biopharma plots phase 3 regulatory path after asthma asset hits mid-stage trial goals
Fierce Biotech
Tue, 12/12/23 - 11:21 am
Connect Biopharma
asthma
clinical trials
rademikibart
Exclusive: Connect Biopharma reports a PhII fail for Zeposia challenger, and execs appear ready to punt
Endpoints
Tue, 05/3/22 - 10:46 pm
Connect Biopharma
Pfizer
Bristol Myers Squibb
FDA
clinical trials
ulcerative colitis
CBP-307
Connect Biopharma celebrates a mid-stage win for its Dupixent rival, but shares tank after investors clamor for data
Endpoints
Fri, 12/17/21 - 10:52 am
Connect Biopharma
Dupixent
China
eczema
clinical trials
Connect Biopharma celebrates a mid-stage win for its Dupixent rival, but shares tank after investors clamor for data
Endpoints
Fri, 11/19/21 - 11:10 am
Connect Biopharma
China
eczema
clinical trials
CBP-201
Dupixent
The Ides of March bring no misfortune to biotech, as industry logs second-busiest IPO week of 2021
Endpoints
Fri, 03/19/21 - 11:22 am
IPOs
NASDAQ
Instil Bio
Connect Biopharma
Finch Therapeutics
Gain Therapeutics
Four IPOs and a SPAC pitch a new slate of microbiome, cancer and inflammatory drugs to Wall Street
Endpoints
Mon, 03/1/21 - 11:42 pm
IPOs
SPAC
Finch Therapeutics
microbiome
Connect Biopharma
Insil Bio
Transcode Therapeutics
Connect Biopharma snags $115 million in Series C to develop arsenal of immune modulators
Endpoints
Tue, 08/25/20 - 12:02 am
Connect Biopharma
Series C
immune modulators